PBS boasts four new cancer therapies
One, a new drug to treat chronic lymphocytic leukaemia, is partly the product of Australian research
![piles of 100 dollar bills](https://www.ausdoc.com.au/wp-content/uploads/2022/08/ThinkstockPhotos-187117985-1.jpg)
A drug co-developed by Australians, venetoclax, is now listed on the PBS for chronic lymphocytic leukaemia.
The drug (Venclexta, AbbVie) was added to the PBS on 1 March along with new indications for therapies to treat renal, urothelial and liver cancers.